{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:55:18Z","timestamp":1794023718968,"version":"4.8.0"},"reference-count":191,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.neurol.2025.06.012","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T15:43:21Z","timestamp":1762962201000},"page":"863-880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prodromal Parkinson's disease"],"prefix":"10.1016","volume":"181","author":[{"given":"L.","family":"Grass","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0849-8213","authenticated-orcid":false,"given":"S.","family":"Grimaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3869-0564","authenticated-orcid":false,"given":"P.","family":"Damier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10423","key":"10.1016\/j.neurol.2025.06.012_bib0960","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0140-6736(23)01419-8","article-title":"The epidemiology of Parkinson's disease","volume":"403","author":"Ben-Shlomo","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2025.06.012_bib0965","doi-asserted-by":"crossref","first-page":"e080952","DOI":"10.1136\/bmj-2024-080952","article-title":"Projections for prevalence of Parkinson's disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021","volume":"388","author":"Su","year":"2025","journal-title":"BMJ"},{"issue":"10291","key":"10.1016\/j.neurol.2025.06.012_bib0970","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.neurol.2025.06.012_bib0975","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.tins.2016.10.008","article-title":"The threshold theory for Parkinson's disease","volume":"40","author":"Engelender","year":"2017","journal-title":"Trends Neurosci"},{"issue":"6","key":"10.1016\/j.neurol.2025.06.012_bib0980","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41582-021-00486-9","article-title":"Prodromal Parkinson disease subtypes\u00a0\u2013\u00a0key to understanding heterogeneity","volume":"17","author":"Berg","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2025.06.012_bib0985","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0021-9681(74)90014-9","article-title":"Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii, and California: demographic, physical, dietary, and biochemical characteristics","volume":"27","author":"Kagan","year":"1974","journal-title":"J Chronic Dis"},{"issue":"9","key":"10.1016\/j.neurol.2025.06.012_bib0990","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1212\/01.wnl.0000183056.89590.0d","article-title":"Excessive daytime sleepiness and subsequent development of Parkinson disease","volume":"65","author":"Abbott","year":"2005","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.neurol.2025.06.012_bib0995","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/oxfordjournals.aje.a116960","article-title":"Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease","volume":"139","author":"Grandinetti","year":"1994","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.neurol.2025.06.012_bib1000","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1001\/jama.283.20.2674","article-title":"Association of coffee and caffeine intake with the risk of Parkinson disease","volume":"283","author":"Ross","year":"2000","journal-title":"JAMA"},{"issue":"Suppl. 1","key":"10.1016\/j.neurol.2025.06.012_bib1005","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1353-8020(11)70062-1","article-title":"Pre-motor features of Parkinson's disease: the Honolulu-Asia Aging Study experience","volume":"18","author":"Ross","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"issue":"Suppl. 1","key":"10.1016\/j.neurol.2025.06.012_bib1010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000110957","article-title":"A community-based study of dementia: the Rotterdam Elderly Study","volume":"11","author":"Breteler","year":"1992","journal-title":"Neuroepidemiology"},{"issue":"11","key":"10.1016\/j.neurol.2025.06.012_bib1015","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10654-007-9199-x","article-title":"The Rotterdam Study: objectives and design update","volume":"22","author":"Hofman","year":"2007","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"10.1016\/j.neurol.2025.06.012_bib1020","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10654-023-01094-1","article-title":"The Rotterdam Study. Design update and major findings between 2020 and 2024","volume":"39","author":"Ikram","year":"2024","journal-title":"Eur J Epidemiol"},{"issue":"12","key":"10.1016\/j.neurol.2025.06.012_bib1025","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S1474-4422(05)70226-X","article-title":"Prevalence of movement disorders in men and women aged 50-89 years (Bruneck Study cohort): a population-based study","volume":"4","author":"Wenning","year":"2005","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2025.06.012_bib1030","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1468-1331.2012.03798.x","article-title":"The PRIPS study: screening battery for subjects at risk for Parkinson's disease","volume":"20","author":"Berg","year":"2013","journal-title":"Eur J Neurol"},{"issue":"5","key":"10.1016\/j.neurol.2025.06.012_bib1035","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/ene.12382","article-title":"Prodromal features for Parkinson's disease--baseline data from the TREND study","volume":"21","author":"Gaenslen","year":"2014","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2025.06.012_bib1040","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/mds.24892","article-title":"Impaired olfaction and other prodromal features in the Parkinson at-risk Syndrome Study","volume":"27","author":"Siderowf","year":"2012","journal-title":"Mov Disord"},{"issue":"19","key":"10.1016\/j.neurol.2025.06.012_bib1045","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1212\/WNL.0000000000000960","article-title":"Imaging prodromal Parkinson disease: the Parkinson associated risk Syndrome Study","volume":"83","author":"Jennings","year":"2014","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurol.2025.06.012_bib1050","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/mds.1120","article-title":"Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy","volume":"16","author":"Boeve","year":"2001","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.neurol.2025.06.012_bib1055","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1212\/01.WNL.0000073619.94467.B0","article-title":"Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism","volume":"61","author":"Boeve","year":"2003","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.neurol.2025.06.012_bib1060","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1212\/01.wnl.0000203648.80727.5b","article-title":"Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder","volume":"66","author":"Postuma","year":"2006","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.neurol.2025.06.012_bib1065","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S1474-4422(06)70476-8","article-title":"Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study","volume":"5","author":"Iranzo","year":"2006","journal-title":"Lancet Neurol"},{"issue":"15","key":"10.1016\/j.neurol.2025.06.012_bib1070","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1002\/mds.22757","article-title":"Idiopathic REM sleep behavior disorder in the transition to degenerative disease","volume":"24","author":"Postuma","year":"2009","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.neurol.2025.06.012_bib1075","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ana.24877","article-title":"The natural history of pure autonomic failure: a U.S. Prospective Cohort","volume":"81","author":"Kaufmann","year":"2017","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2025.06.012_bib1080","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41582-019-0301-2","article-title":"LRRK2 in Parkinson disease: challenges of clinical trials","volume":"16","author":"Tolosa","year":"2020","journal-title":"Nat Rev Neurol"},{"issue":"7 Suppl. 1","key":"10.1016\/j.neurol.2025.06.012_bib1085","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1212\/WNL.0000000000200238","article-title":"What to test in Parkinson disease prevention trials? Repurposed, low-risk, and gene-targeted drugs","volume":"99","author":"Crotty","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2025.06.012_bib1090","unstructured":"About Parkinson's Progression Markers Initiative. Accessed September 5, 2024. https:\/\/www.ppmi-info.org\/about-ppmi."},{"issue":"5","key":"10.1016\/j.neurol.2025.06.012_bib1095","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","article-title":"Parkinson's Progression Markers Initiative. Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using alpha-synuclein seed amplification: a cross-sectional study","volume":"22","author":"Siderowf","year":"2023","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.neurol.2025.06.012_bib1100","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3233\/JPD-230446","article-title":"Modeling of Parkinson's disease progression and implications for detection of disease modification in treatment trials","volume":"14","author":"Ribba","year":"2024","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.neurol.2025.06.012_bib1105","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/brain\/aws093","article-title":"How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder","volume":"135","author":"Postuma","year":"2012","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.neurol.2025.06.012_bib1110","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/mds.27792","article-title":"Motor function and the probability of prodromal Parkinson's disease in older adults","volume":"34","author":"Maraki","year":"2019","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.neurol.2025.06.012_bib1115","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/jamaneurol.2022.3902","article-title":"Widening the spectrum of risk factors, comorbidities, and prodromal features of Parkinson Disease","volume":"80","author":"Schrag","year":"2023","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2025.06.012_bib1120","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1212\/01.WNL.0000072330.07328.D6","article-title":"Parkinsonian signs in older people: prevalence and associations with smoking and coffee","volume":"61","author":"Louis","year":"2003","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.neurol.2025.06.012_bib1125","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/mds.21433","article-title":"Mild Parkinsonian signs: an overview of an emerging concept","volume":"22","author":"Louis","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2025.06.012_bib1130","doi-asserted-by":"crossref","first-page":"104749","DOI":"10.1016\/j.neubiorev.2022.104749","article-title":"Prevalence and clinical aspects of depression in Parkinson's disease: a systematic review and meta-analysis of 129 studies","volume":"141","author":"Cong","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"10.1016\/j.neurol.2025.06.012_bib1135","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/mds.21803","article-title":"A systematic review of prevalence studies of depression in Parkinson's disease","volume":"23","author":"Reijnders","year":"2008","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.neurol.2025.06.012_bib1140","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/jnnp.2008.152983","article-title":"Use of antidepressants and the risk of Parkinson's disease: a prospective study","volume":"80","author":"Alonso","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"10.1016\/j.neurol.2025.06.012_bib1145","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/mds.23092","article-title":"Depression and the subsequent risk of Parkinson's disease in the NIH-AARP Diet and Health Study","volume":"25","author":"Fang","year":"2010","journal-title":"Mov Disord"},{"issue":"10","key":"10.1016\/j.neurol.2025.06.012_bib1150","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1212\/WNL.58.10.1501","article-title":"Increased risk of Parkinson's disease after depression: a retrospective cohort study","volume":"58","author":"Schuurman","year":"2002","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.neurol.2025.06.012_bib1155","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.parkreldis.2010.06.014","article-title":"Occurrence of depression and anxiety prior to Parkinson's disease","volume":"16","author":"Jacob","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"10.1016\/j.neurol.2025.06.012_bib1160","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/mds.10425","article-title":"Prospective study of phobic anxiety and risk of Parkinson's disease","volume":"18","author":"Weisskopf","year":"2003","journal-title":"Mov Disord"},{"issue":"13","key":"10.1016\/j.neurol.2025.06.012_bib1165","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/mds.23230","article-title":"Anxious personality predicts an increased risk of Parkinson's disease","volume":"25","author":"Bower","year":"2010","journal-title":"Mov Disord"},{"issue":"12","key":"10.1016\/j.neurol.2025.06.012_bib1170","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/j.1468-1331.2009.02707.x","article-title":"Cognitive function in early Parkinson's disease: a population-based study","volume":"16","author":"Elgh","year":"2009","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2025.06.012_bib1175","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diagnostic Criteria for Mild Cognitive Impairment in Parkinson's Disease: Movement Disorder Society Task Force Guidelines","volume":"27","author":"Litvan","year":"2012","journal-title":"Mov Disord"},{"issue":"17","key":"10.1016\/j.neurol.2025.06.012_bib1180","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","article-title":"Research criteria for the diagnosis of prodromal dementia with Lewy bodies","volume":"94","author":"McKeith","year":"2020","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.neurol.2025.06.012_bib1185","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1093\/brain\/awz111","article-title":"Evolution of prodromal Parkinson's disease and dementia with Lewy bodies: a prospective study","volume":"142","author":"Fereshtehnejad","year":"2019","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.neurol.2025.06.012_bib1190","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3233\/JPD-240002","article-title":"Parkinson's disease and dementia with Lewy bodies: one and the same","volume":"14","author":"Borghammer","year":"2024","journal-title":"J Parkinsons Dis"},{"issue":"13","key":"10.1016\/j.neurol.2025.06.012_bib1195","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1212\/01.wnl.0000338632.00552.cb","article-title":"Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study","volume":"72","author":"Aarsland","year":"2009","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.neurol.2025.06.012_bib1200","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1001\/jamaneurol.2017.2248","article-title":"Association between poor cognitive functioning and risk of incident Parkinsonism: the Rotterdam Study","volume":"74","author":"Darweesh","year":"2017","journal-title":"JAMA Neurol"},{"issue":"4","key":"10.1016\/j.neurol.2025.06.012_bib1205","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1212\/WNL.0000000000000066","article-title":"Characterizing mild cognitive impairment in incident Parkinson disease","volume":"82","author":"Yarnall","year":"2014","journal-title":"Neurology"},{"issue":"13","key":"10.1016\/j.neurol.2025.06.012_bib1210","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1001\/jama.1987.03390130104038","article-title":"Rapid eye movement sleep behavior disorder. A treatable parasomnia affecting older adults","volume":"257","author":"Schenck","year":"1987","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.neurol.2025.06.012_bib1215","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/brain\/123.2.331","article-title":"Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases","volume":"123","author":"Olson","year":"2000","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neurol.2025.06.012_bib1220","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.sleep.2007.11.019","article-title":"Idiopathic rapid-eye-movement sleep disorder: associations with antidepressants, psychiatric diagnoses, and other factors, in relation to age of onset","volume":"10","author":"Teman","year":"2009","journal-title":"Sleep Med"},{"issue":"2","key":"10.1016\/j.neurol.2025.06.012_bib1225","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1212\/WNL.46.2.388","article-title":"Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder","volume":"46","author":"Schenck","year":"1996","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.neurol.2025.06.012_bib1230","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.sleep.2012.10.009","article-title":"Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series","volume":"14","author":"Schenck","year":"2013","journal-title":"Sleep Med"},{"issue":"2","key":"10.1016\/j.neurol.2025.06.012_bib1235","doi-asserted-by":"crossref","first-page":"e89741","DOI":"10.1371\/journal.pone.0089741","article-title":"Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients","volume":"9","author":"Iranzo","year":"2014","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/j.neurol.2025.06.012_bib1240","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1212\/01.wnl.0000340980.19702.6e","article-title":"Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder","volume":"72","author":"Postuma","year":"2009","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurol.2025.06.012_bib1245","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/jnnp-2011-301232","article-title":"Prospective outcome of rapid eye movement sleep behaviour disorder: psychiatric disorders as a potential early marker of Parkinson's disease","volume":"83","author":"Wing","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.neurol.2025.06.012_bib1250","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/brain\/awz030","article-title":"Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study","volume":"142","author":"Postuma","year":"2019","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.neurol.2025.06.012_bib1255","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.sleep.2013.02.016","article-title":"Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group","volume":"14","author":"Schenck","year":"2013","journal-title":"Sleep Med"},{"issue":"7 Suppl. 1","key":"10.1016\/j.neurol.2025.06.012_bib1260","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1212\/WNL.0000000000200235","article-title":"Neuroprotective trials in REM sleep behavior disorder: the way forward becomes clearer","volume":"99","author":"Postuma","year":"2022","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurol.2025.06.012_bib1265","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/acn3.51738","article-title":"Baseline characteristics of the North American prodromal Synucleinopathy cohort","volume":"10","author":"Elliott","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"issue":"8","key":"10.1016\/j.neurol.2025.06.012_bib1270","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1093\/brain\/awad072","article-title":"Progression of clinical markers in prodromal Parkinson's disease and dementia with Lewy bodies: a multicentre study","volume":"146","author":"Joza","year":"2023","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.neurol.2025.06.012_bib1275","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/mds.26077","article-title":"The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD study)","volume":"30","author":"Pont-Sunyer","year":"2015","journal-title":"Mov Disord"},{"issue":"1\u20132","key":"10.1016\/j.neurol.2025.06.012_bib1280","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jns.2011.08.012","article-title":"A study of the prevalence of restless legs syndrome in previously untreated Parkinson's disease patients: absence of co-morbid association","volume":"310","author":"Angelini","year":"2011","journal-title":"J Neurol Sci"},{"issue":"22","key":"10.1016\/j.neurol.2025.06.012_bib1285","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1212\/WNL.0b013e31823a0cc8","article-title":"Increased risk of leg motor restlessness but not RLS in early Parkinson disease","volume":"77","author":"Gjerstad","year":"2011","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurol.2025.06.012_bib1290","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/jnnp-2013-306851","article-title":"Accelerometer-based quantitative analysis of axial nocturnal movements differentiates patients with Parkinson's disease, but not high-risk individuals, from controls","volume":"86","author":"Louter","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.neurol.2025.06.012_bib1295","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/jnnp.62.5.436","article-title":"Olfactory dysfunction in Parkinson's disease","volume":"62","author":"Hawkes","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.neurol.2025.06.012_bib1300","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ana.21291","article-title":"Association of olfactory dysfunction with risk for future Parkinson's disease","volume":"63","author":"Ross","year":"2008","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2025.06.012_bib1305","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0031-9384(84)90269-5","article-title":"Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function","volume":"32","author":"Doty","year":"1984","journal-title":"Physiol Behav"},{"issue":"8","key":"10.1016\/j.neurol.2025.06.012_bib1310","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s00415-019-09340-x","article-title":"Screening performance of abbreviated versions of the UPSIT smell test","volume":"266","author":"Joseph","year":"2019","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2025.06.012_bib1315","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00405-006-0173-0","article-title":"Normative data for the \u201cSniffin\u2019 Sticks\u201d including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects","volume":"264","author":"Hummel","year":"2007","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.neurol.2025.06.012_bib1320","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41531-017-0039-8","article-title":"Optimizing olfactory testing for the diagnosis of Parkinson's disease: item analysis of the university of Pennsylvania smell identification test","volume":"4","author":"Morley","year":"2018","journal-title":"Parkinsons Dis"},{"key":"10.1016\/j.neurol.2025.06.012_bib1325","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.parkreldis.2019.12.008","article-title":"Midbrain hyperechogenicity, hyposmia, mild parkinsonian signs and risk for incident Parkinson's disease over 10 years: a prospective population-based study","volume":"70","author":"Mahlknecht","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"10.1016\/j.neurol.2025.06.012_bib1330","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/ana.20160","article-title":"Idiopathic hyposmia as a preclinical sign of Parkinson's disease","volume":"56","author":"Ponsen","year":"2004","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.neurol.2025.06.012_bib1335","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/jnnp.2009.183715","article-title":"Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson's disease","volume":"81","author":"Ponsen","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"14","key":"10.1016\/j.neurol.2025.06.012_bib1340","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1212\/WNL.0000000000004382","article-title":"Olfaction and incident Parkinson disease in US white and black older adults","volume":"89","author":"Chen","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2025.06.012_bib1345","doi-asserted-by":"crossref","first-page":"648588","DOI":"10.3389\/fneur.2021.648588","article-title":"Genotype-phenotype correlations in monogenic Parkinson disease: a review on clinical and molecular findings","volume":"12","author":"Guadagnolo","year":"2021","journal-title":"Front Neurol"},{"issue":"7","key":"10.1016\/j.neurol.2025.06.012_bib1350","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/chemse\/bjx025","article-title":"Anosmia\u00a0\u2014\u00a0a clinical review","volume":"42","author":"Boesveldt","year":"2017","journal-title":"Chem Senses"},{"issue":"10","key":"10.1016\/j.neurol.2025.06.012_bib1355","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.visres.2004.11.006","article-title":"Visual and spatial symptoms in Parkinson's disease","volume":"45","author":"Davidsdottir","year":"2005","journal-title":"Vision Res"},{"issue":"11","key":"10.1016\/j.neurol.2025.06.012_bib1360","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1093\/brain\/aww175","article-title":"Visual dysfunction in Parkinson's disease","volume":"139","author":"Weil","year":"2016","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neurol.2025.06.012_bib1365","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/jnnp-2024-333865","article-title":"Visuospatial dysfunction predicts dementia-first phenoconversion in isolated REM sleep behaviour disorder","volume":"96","author":"Wang","year":"2024","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2025.06.012_bib1370","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.parkreldis.2016.05.016","article-title":"Constipation and risk of Parkinson's disease: a Danish population-based cohort study","volume":"28","author":"Svensson","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"10.1016\/j.neurol.2025.06.012_bib1375","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/jnnp-2015-311680","article-title":"Constipation preceding Parkinson's disease: a systematic review and meta-analysis","volume":"87","author":"Adams-Carr","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.neurol.2025.06.012_bib1380","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/jnnp-2021-328062","article-title":"Possible predictors of phenoconversion in isolated REM sleep behaviour disorder: a systematic review and meta-analysis","volume":"93","author":"Wang","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"14","key":"10.1016\/j.neurol.2025.06.012_bib1385","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1002\/mds.23348","article-title":"Exploring the electrocardiogram as a potential tool to screen for premotor Parkinson's disease","volume":"25","author":"Valappil","year":"2010","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.neurol.2025.06.012_bib1390","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/mds.22844","article-title":"Baroreflex sensitivity and power spectral analysis during autonomic testing in different extrapyramidal syndromes","volume":"25","author":"Friedrich","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2025.06.012_bib1395","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3389\/fneur.2020.00610","article-title":"A neurologist's guide to REM sleep behavior disorder","volume":"11","author":"Roguski","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.neurol.2025.06.012_bib1400","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3390\/brainsci13101398","article-title":"Biomarkers in isolated rapid eye movement sleep behavior disorder: where are we? A systematic review","volume":"13","author":"Grimaldi","year":"2023","journal-title":"Brain Sciences"},{"key":"10.1016\/j.neurol.2025.06.012_bib1405","doi-asserted-by":"crossref","first-page":"102421","DOI":"10.1016\/j.nicl.2020.102421","article-title":"Cortical gray matter progression in idiopathic REM sleep behavior disorder and its relation to cognitive decline","volume":"28","author":"Campabadal","year":"2020","journal-title":"NeuroImage Clin"},{"key":"10.1016\/j.neurol.2025.06.012_bib1410","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1093\/brain\/awac187","article-title":"Brain atrophy in prodromal synucleinopathy is shaped by structural connectivity and gene expression","volume":"145","author":"Rahayel","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2025.06.012_bib1415","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40035-023-00356-y","article-title":"Longitudinal evolution of cortical thickness signature reflecting Lewy body dementia in isolated REM sleep behavior disorder: a prospective cohort study","volume":"12","author":"Shin","year":"2023","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.neurol.2025.06.012_bib1420","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ana.25962","article-title":"A prodromal brain-clinical pattern of cognition in synucleinopathies","volume":"89","author":"Rahayel","year":"2021","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2025.06.012_bib1425","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/mds.28895","article-title":"Disruption of brainstem structural connectivity in REM sleep behavior disorder using 7 Tesla magnetic resonance imaging","volume":"37","author":"Garc\u00eda-Gomar","year":"2022","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.neurol.2025.06.012_bib1430","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41572-018-0016-5","article-title":"REM sleep behaviour disorder","volume":"4","author":"Dauvilliers","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"10.1016\/j.neurol.2025.06.012_bib1435","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/ane.13573","article-title":"Glymphatic dysfunction in isolated REM sleep behavior disorder","volume":"145","author":"Lee","year":"2022","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"10.1016\/j.neurol.2025.06.012_bib1440","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41531-025-00962-9","article-title":"Parkinson's disease with possible REM sleep behavior disorder correlated with more severe glymphatic system dysfunction","volume":"11","author":"Ma","year":"2025","journal-title":"Parkinsons Dis"},{"key":"10.1016\/j.neurol.2025.06.012_bib1445","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/mds.27929","article-title":"Quantitative evaluation of iron content in idiopathic rapid eye movement sleep behavior disorder","volume":"35","author":"Sun","year":"2020","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2025.06.012_bib1450","first-page":"112","article-title":"Magnetic susceptibility changes in the brainstem reflect REM sleep without atonia severity in isolated REM sleep behavior disorder","volume":"9","author":"Nepozitek","year":"2023","journal-title":"Parkinson's Dis"},{"key":"10.1016\/j.neurol.2025.06.012_bib1455","doi-asserted-by":"crossref","first-page":"e26675","DOI":"10.1002\/hbm.26675","article-title":"Whole brain pattern of iron accumulation in REM sleep behavior disorder","volume":"45","author":"Varga","year":"2024","journal-title":"Human Brain Mapping"},{"key":"10.1016\/j.neurol.2025.06.012_bib1460","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1093\/brain\/awab191","article-title":"The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson's disease","volume":"144","author":"Biondetti","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2025.06.012_bib1465","doi-asserted-by":"crossref","first-page":"119454","DOI":"10.1016\/j.neuroimage.2022.119454","article-title":"Evaluation of iron overload in nigrosome 1 via quantitative susceptibility mapping as a progression biomarker in prodromal stages of synucleinopathies","volume":"260","author":"Lancione","year":"2022","journal-title":"NeuroImage"},{"key":"10.1016\/j.neurol.2025.06.012_bib1470","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/brain\/aww006","article-title":"The coeruleus\/subcoeruleus complex in idiopathic rapid eye movement sleep behaviour disorder","volume":"139","author":"Ehrminger","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2025.06.012_bib1475","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S1474-4422(10)70216-7","article-title":"Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study","volume":"9","author":"Iranzo","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2025.06.012_bib1480","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/mds.26055","article-title":"Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder: transcranial sonography in REM sleep behavior disorder","volume":"29","author":"Iranzo","year":"2014","journal-title":"Mov Disord"},{"issue":"11","key":"10.1016\/j.neurol.2025.06.012_bib1485","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/ene.12444","article-title":"[123I] FP-CIT SPECT (Da TSCAN) may be a useful tool to differentiate between P arkinson's disease and vascular or drug-induced parkinsonisms: a meta-analysis","volume":"21","author":"Brigo","year":"2014","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2025.06.012_bib1490","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/jnnp-2022-330048","article-title":"Prognostic biomarkers in prodromal \u03b1-synucleinopathies: DAT binding and REM sleep without atonia","volume":"94","author":"Kunz","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2025.06.012_bib1495","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/acn3.51269","article-title":"Dopamine transporter imaging predicts clinically-defined \u03b1 -synucleinopathy in REM sleep behavior disorder","volume":"8","author":"Chahine","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.neurol.2025.06.012_bib1500","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/jamaneurol.2017.0985","article-title":"Conversion to Parkinson disease in the PARS hyposmic and dopamine transporter-deficit prodromal cohort","volume":"74","author":"Jennings","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2025.06.012_bib1505","doi-asserted-by":"crossref","first-page":"105626","DOI":"10.1016\/j.nbd.2022.105626","article-title":"Clinical and imaging evidence of brain-first and body-first Parkinson's disease","volume":"164","author":"Horsager","year":"2022","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurol.2025.06.012_bib1510","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/mdc3.12697","article-title":"MIBG myocardial scintigraphy identifies premotor PD\/DLB during a negative DAT scan period: second report: Mibg test identifies premotor PD\/DLB","volume":"6","author":"Sakakibara","year":"2019","journal-title":"Mov Disord Clin Pract"},{"issue":"3","key":"10.1016\/j.neurol.2025.06.012_bib1515","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae148","article-title":"Reduced cardiac (123)I-MIBG uptake is a robust biomarker of Lewy body disease in isolated rapid eye movement sleep behaviour disorder","volume":"6","author":"Miyamoto","year":"2024","journal-title":"Brain Commun"},{"key":"10.1016\/j.neurol.2025.06.012_bib1520","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S1474-4422(18)30162-5","article-title":"In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study","volume":"17","author":"Knudsen","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2025.06.012_bib1525","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/ana.26187","article-title":"Single photon emission computed tomography\/positron emission tomography molecular imaging for Parkinsonism: a fast-developing field","volume":"90","author":"Verger","year":"2021","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2025.06.012_bib1530","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1093\/brain\/awu290","article-title":"Consistent abnormalities in metabolic network activity in idiopathic rapid eye movement sleep behaviour disorder","volume":"137","author":"Wu","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2025.06.012_bib1535","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3390\/ph14090847","article-title":"Alpha-Synuclein PET Tracer Development\u00a0\u2014\u00a0an overview about current efforts","volume":"14","author":"Korat","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.neurol.2025.06.012_bib1540","doi-asserted-by":"crossref","first-page":"6750","DOI":"10.1038\/s41467-023-42305-3","article-title":"The \u03b1-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases","volume":"14","author":"Smith","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.neurol.2025.06.012_bib1545","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","article-title":"A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria","volume":"23","author":"H\u00f6glinger","year":"2024","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2025.06.012_bib1550","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","article-title":"A biological definition of neuronal \u03b1-synuclein disease: towards an integrated staging system for research","volume":"23","author":"Simuni","year":"2024","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2025.06.012_bib1555","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.parkreldis.2022.10.007","article-title":"Diagnostic value of \u03b1-synuclein seeding amplification assays in \u03b1-synucleinopathies: a systematic review and meta-analysis","volume":"104","author":"Yoo","year":"2022","journal-title":"Park Related Disord"},{"key":"10.1016\/j.neurol.2025.06.012_bib1560","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41582-024-01004-3","article-title":"Disentangling clinical and biological trajectories of neurodegenerative diseases","volume":"20","author":"Villain","year":"2024","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2025.06.012_bib1565","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41582-024-00955-x","article-title":"Neurofilaments as biomarkers in neurological disorders\u00a0\u2014\u00a0towards clinical application","volume":"20","author":"Khalil","year":"2024","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2025.06.012_bib1570","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00702-023-02632-7","article-title":"Blood neurofilament light chain in Parkinson's disease","volume":"130","author":"Buhmann","year":"2023","journal-title":"J Neural Transm"},{"key":"10.1016\/j.neurol.2025.06.012_bib1575","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3233\/JAD-190615","article-title":"Neurofilament light chain in cerebrospinal fluid and blood as a biomarker for neurodegenerative diseases: a systematic review and meta-analysis","volume":"72","author":"Wang","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neurol.2025.06.012_bib1580","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3233\/JPD-223519","article-title":"Neurofilament light protein predicts disease progression in idiopathic REM sleep behavior disorder","volume":"13","author":"Zhang","year":"2023","journal-title":"J Parkinsons Dis"},{"issue":"12","key":"10.1016\/j.neurol.2025.06.012_bib1585","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord"},{"issue":"11","key":"10.1016\/j.neurol.2025.06.012_bib1590","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1002\/mds.26721","article-title":"Arguing against the proposed definition changes of PD","volume":"31","author":"Boeve","year":"2016","journal-title":"Mov Disord"},{"issue":"12","key":"10.1016\/j.neurol.2025.06.012_bib1595","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/mds.26431","article-title":"MDS research criteria for prodromal Parkinson's disease","volume":"30","author":"Berg","year":"2015","journal-title":"Mov Disord"},{"issue":"10","key":"10.1016\/j.neurol.2025.06.012_bib1600","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/mds.27802","article-title":"Update of the MDS research criteria for prodromal Parkinson's disease","volume":"34","author":"Heinzel","year":"2019","journal-title":"Mov Disord"},{"issue":"9","key":"10.1016\/j.neurol.2025.06.012_bib1605","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/mds.26674","article-title":"Prodromal Parkinson's disease as defined per MDS research criteria in the general elderly community","volume":"31","author":"Mahlknecht","year":"2016","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.neurol.2025.06.012_bib1610","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/mds.27281","article-title":"Performance of the Movement Disorders Society criteria for prodromal Parkinson's disease: a population-based 10-year study","volume":"33","author":"Mahlknecht","year":"2018","journal-title":"Mov Disord"},{"issue":"10","key":"10.1016\/j.neurol.2025.06.012_bib1615","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/mds.28145","article-title":"A prospective validation of the updated movement disorders Society Research Criteria for prodromal Parkinson's Disease","volume":"35","author":"Giagkou","year":"2020","journal-title":"Mov Disord"},{"issue":"7","key":"10.1016\/j.neurol.2025.06.012_bib1620","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/mds.27035","article-title":"Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts","volume":"32","author":"Pilotto","year":"2017","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.neurol.2025.06.012_bib1625","first-page":"125","article-title":"A retrospective study of the MDS criteria for prodromal Parkinson's disease in the general population","volume":"10","author":"de Klerk","year":"2024","journal-title":"Parkinson's Dis"},{"issue":"12","key":"10.1016\/j.neurol.2025.06.012_bib1630","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1007\/s00415-020-10048-6","article-title":"Prodromal Parkinson disease in patients with idiopathic hyposmia","volume":"267","author":"Marrero-Gonz\u00e1lez","year":"2020","journal-title":"J Neurol"},{"issue":"6","key":"10.1016\/j.neurol.2025.06.012_bib1635","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/mds.26989","article-title":"Validation of the MDS research criteria for prodromal Parkinson's disease: Longitudinal assessment in a REM sleep behavior disorder (RBD) cohort","volume":"32","author":"Fereshtehnejad","year":"2017","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.neurol.2025.06.012_bib1640","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/mds.27342","article-title":"Application of the Movement Disorder Society Prodromal Criteria in healthy G2019S-LRRK2 carriers","volume":"33","author":"Mirelman","year":"2018","journal-title":"Mov Disord"},{"issue":"9","key":"10.1016\/j.neurol.2025.06.012_bib1645","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/mds.27775","article-title":"Evolution and clustering of prodromal parkinsonian features in GBA1 carriers","volume":"34","author":"Mullin","year":"2019","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.neurol.2025.06.012_bib1650","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1515\/revneuro-2022-0012","article-title":"Predictive models for the incidence of Parkinson's disease: systematic review and critical appraisal","volume":"34","author":"Chen","year":"2023","journal-title":"Rev Neurosci"},{"issue":"1","key":"10.1016\/j.neurol.2025.06.012_bib1655","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41531-021-00176-9","article-title":"Improving estimation of Parkinson's disease risk-the enhanced PREDICT-PD algorithm","volume":"7","author":"Bestwick","year":"2021","journal-title":"Parkinsons Dis"},{"issue":"9","key":"10.1016\/j.neurol.2025.06.012_bib1660","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/mds.28127","article-title":"Application of a Simple Parkinson's Disease Risk Score in a longitudinal population-based cohort","volume":"35","author":"Marini","year":"2020","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2025.06.012_bib1665","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.sleep.2015.12.016","article-title":"Screening for prodromal Parkinson's disease in the general community: a sleep-based approach","volume":"21","author":"Postuma","year":"2016","journal-title":"Sleep Med"},{"issue":"6","key":"10.1016\/j.neurol.2025.06.012_bib1670","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/brain\/awh445","article-title":"Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system","volume":"128","author":"Remy","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2025.06.012_bib1675","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bbr.2018.03.011","article-title":"Abnormal ventral tegmental area-anterior cingulate cortex connectivity in Parkinson's disease with depression","volume":"347","author":"Wei","year":"2018","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neurol.2025.06.012_bib1680","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3389\/fpsyt.2018.00723","article-title":"An investigation on the clinical features and neurochemical changes in Parkinson's disease with depression","volume":"9","author":"Lian","year":"2018","journal-title":"Front. Psychiatry"},{"issue":"8","key":"10.1016\/j.neurol.2025.06.012_bib1685","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1001\/archgenpsychiatry.2009.106","article-title":"Reduced alpha4beta2*-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease","volume":"66","author":"Meyer","year":"2009","journal-title":"Arch Gen Psychiatry"},{"issue":"12","key":"10.1016\/j.neurol.2025.06.012_bib1690","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/mds.22212","article-title":"Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASB","volume":"23","author":"Boileau","year":"2008","journal-title":"Mov Disord"},{"issue":"8","key":"10.1016\/j.neurol.2025.06.012_bib1695","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.parkreldis.2015.05.016","article-title":"Reduced plasma serotonin and 5-hydroxyindoleacetic acid levels in Parkinson's disease are associated with nonmotor symptoms","volume":"21","author":"Tong","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"10.1016\/j.neurol.2025.06.012_bib1700","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrneurol.2011.189","article-title":"Depression in Parkinson disease\u00a0\u2013\u00a0epidemiology, mechanisms and management","volume":"8","author":"Aarsland","year":"2011","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2025.06.012_bib1705","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ana.24859","article-title":"Serotonin transporter in Parkinson's disease: a meta-analysis of positron emission tomography studies","volume":"81","author":"Pagano","year":"2017","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2025.06.012_bib1710","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.1016\/j.neurol.2025.06.012_bib1715","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-023-00622-7","article-title":"Neuropathology of incidental Lewy body & prodromal Parkinson's disease","volume":"18","author":"Koeglsperger","year":"2023","journal-title":"Mol Neurodegener"},{"issue":"22","key":"10.1016\/j.neurol.2025.06.012_bib1720","doi-asserted-by":"crossref","first-page":"6272","DOI":"10.1016\/j.cell.2024.08.046","article-title":"A pontine-medullary loop crucial for REM sleep and its deficit in Parkinson's disease","volume":"187","author":"Kashiwagi","year":"2024","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.neurol.2025.06.012_bib1725","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/mds.22464","article-title":"Biopsies of olfactory epithelium in patients with Parkinson's disease","volume":"24","author":"Witt","year":"2009","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.neurol.2025.06.012_bib1730","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1093\/brain\/awq079","article-title":"Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease","volume":"133","author":"Bohnen","year":"2010","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.neurol.2025.06.012_bib1735","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1093\/brain\/awt234","article-title":"Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease","volume":"136","author":"Scherfler","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2025.06.012_bib1740","first-page":"1427","article-title":"Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography","volume":"4","author":"Aaker","year":"2010","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"10.1016\/j.neurol.2025.06.012_bib1745","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.3390\/ijms24054391","article-title":"The role of alpha-synuclein deposits in Parkinson's disease: a focus on the human retina","volume":"24","author":"Di Pippo","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.neurol.2025.06.012_bib1750","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","article-title":"Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology","volume":"396","author":"Braak","year":"2006","journal-title":"Neurosci Lett"},{"issue":"12","key":"10.1016\/j.neurol.2025.06.012_bib1755","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1136\/gut.2008.162503","article-title":"Pathological lesions in colonic biopsies during Parkinson's disease","volume":"57","author":"Lebouvier","year":"2008","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.neurol.2025.06.012_bib1760","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00401-013-1214-6","article-title":"Accumulation of \u03b1-synuclein in the bowel of patients in the pre-clinical phase of Parkinson's disease","volume":"127","author":"Hilton","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.1016\/j.neurol.2025.06.012_bib1765","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.24648","article-title":"Pathological \u03b1-synuclein in gastrointestinal tissues from prodromal Parkinson disease patients","volume":"79","author":"Stokholm","year":"2016","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2025.06.012_bib1770","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/brain\/awu369","article-title":"Imaging acetylcholinesterase density in peripheral organs in Parkinson's disease with 11C-donepezil PET","volume":"138","author":"Gjerl\u00f8ff","year":"2015","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.neurol.2025.06.012_bib1775","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1212\/WNL.0000000000003633","article-title":"Decreased intestinal acetylcholinesterase in early Parkinson disease: an 11C-donepezil PET study","volume":"88","author":"Fedorova","year":"2017","journal-title":"Neurology"},{"issue":"Pt 3","key":"10.1016\/j.neurol.2025.06.012_bib1780","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/brain\/awm302","article-title":"Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease","volume":"131","author":"Orimo","year":"2008","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.neurol.2025.06.012_bib1785","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.parkreldis.2011.02.001","article-title":"Sensitivity and specificity of metaiodobenzylguanidine (MIBG) myocardial accumulation in the diagnosis of Lewy body diseases in a movement disorder clinic","volume":"17","author":"Tateno","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"10.1016\/j.neurol.2025.06.012_bib1790","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.parkreldis.2013.11.001","article-title":"MIBG myocardial scintigraphy in pre-motor Parkinson's disease: a review","volume":"20","author":"Sakakibara","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"10.1016\/j.neurol.2025.06.012_bib1795","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","article-title":"Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease","volume":"14","author":"Kordower","year":"2008","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.neurol.2025.06.012_bib1800","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm1746","article-title":"Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation","volume":"14","author":"Li","year":"2008","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.neurol.2025.06.012_bib1805","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1172\/JCI43366","article-title":"\u03b1-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells","volume":"121","author":"Hansen","year":"2011","journal-title":"J Clin Invest"},{"issue":"6248","key":"10.1016\/j.neurol.2025.06.012_bib1810","doi-asserted-by":"crossref","first-page":"1255555","DOI":"10.1126\/science.1255555","article-title":"Alzheimer's and Parkinson's diseases: the prion concept in relation to assembled Abeta, tau, and alpha-synuclein","volume":"349","author":"Goedert","year":"2015","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.neurol.2025.06.012_bib1815","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/WCO.0000000000000349","article-title":"How strong is the evidence that Parkinson's disease is a prion disorder?","volume":"29","author":"Brundin","year":"2016","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.neurol.2025.06.012_bib1820","doi-asserted-by":"crossref","first-page":"106077","DOI":"10.1016\/j.parkreldis.2024.106077","article-title":"Loss of monomeric alpha-synuclein (synucleinopenia) and the origin of Parkinson's disease","volume":"122","author":"Espay","year":"2024","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"10.1016\/j.neurol.2025.06.012_bib1825","doi-asserted-by":"crossref","first-page":"7497","DOI":"10.1038\/s41467-023-43213-2","article-title":"A primate nigrostriatal atlas of neuronal vulnerability and resilience in a model of Parkinson's disease","volume":"14","author":"Tang","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.neurol.2025.06.012_bib1830","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41531-024-00777-0","article-title":"Calbindin and Girk2\/Aldh1a1 define resilient vs vulnerable dopaminergic neurons in a primate Parkinson's disease model","volume":"10","author":"Del Rey","year":"2024","journal-title":"Parkinsons Dis"},{"issue":"9","key":"10.1016\/j.neurol.2025.06.012_bib1835","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.3390\/cells9092045","article-title":"Calcium, bioenergetics, and Parkinson's disease","volume":"9","author":"Zampese","year":"2020","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.neurol.2025.06.012_bib1840","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/ana.21541","article-title":"A critical evaluation of the Braak staging scheme for Parkinson's disease","volume":"64","author":"Burke","year":"2008","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2025.06.012_bib1845","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2990.2007.00923.x","article-title":"The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of alpha-synuclein staging","volume":"34","author":"Kalaitzakis","year":"2008","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"4","key":"10.1016\/j.neurol.2025.06.012_bib1850","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00702-018-1898-9","article-title":"Is Braak staging valid for all types of Parkinson's disease?","volume":"126","author":"Jellinger","year":"2019","journal-title":"J Neural Transm"},{"issue":"1","key":"10.1016\/j.neurol.2025.06.012_bib1855","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ana.20321","article-title":"Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia","volume":"57","author":"Parkkinen","year":"2005","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2025.06.012_bib1860","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3233\/JPD-2011-11046","article-title":"Disentangling the relationship between lewy bodies and nigral neuronal loss in Parkinson's disease","volume":"1","author":"Parkkinen","year":"2011","journal-title":"J Parkinson's Dis"},{"issue":"24","key":"10.1016\/j.neurol.2025.06.012_bib1865","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1212\/WNL.0b013e318278fe32","article-title":"Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease","volume":"79","author":"Milber","year":"2012","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.neurol.2025.06.012_bib1870","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1093\/brain\/awad059","article-title":"Pathological combinations in neurodegenerative disease are heterogeneous and disease-associated","volume":"146","author":"Robinson","year":"2023","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.neurol.2025.06.012_bib1875","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41583-020-00416-6","article-title":"Reverse engineering Lewy bodies: how far have we come and how far can we go?","volume":"22","author":"Fares","year":"2021","journal-title":"Nat Rev Neurosci"},{"issue":"Suppl. 2","key":"10.1016\/j.neurol.2025.06.012_bib1880","article-title":"Brain-first versus gut-first Parkinson's disease: a hypothesis","volume":"9","author":"Borghammer","year":"2019","journal-title":"J Parkinsons Dis"},{"issue":"10","key":"10.1016\/j.neurol.2025.06.012_bib1885","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1093\/brain\/awaa238","article-title":"Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study","volume":"143","author":"Horsager","year":"2020","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.neurol.2025.06.012_bib1890","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41582-021-00486-9","article-title":"Prodromal Parkinson disease subtypes - key to understanding heterogeneity","volume":"17","author":"Berg","year":"2021","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"10.1016\/j.neurol.2025.06.012_bib1895","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1093\/brain\/awf251","article-title":"Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease","volume":"125","author":"Harding","year":"2002","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neurol.2025.06.012_bib1900","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s40478-019-0787-2","article-title":"Unique \u03b1-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression","volume":"7","author":"Sorrentino","year":"2019","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"10.1016\/j.neurol.2025.06.012_bib1905","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/mds.28462","article-title":"Motor onset topography and progression in Parkinson's disease: the upper limb is first","volume":"36","author":"Monje","year":"2021","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.neurol.2025.06.012_bib1910","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41583-021-00542-9","article-title":"Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?","volume":"23","author":"Blesa","year":"2022","journal-title":"Nat Rev Neurosci"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378725005739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378725005739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T03:36:22Z","timestamp":1763177782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378725005739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":191,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0035378725005739"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2025.06.012","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prodromal Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2025.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}